47 results
Page 2 of 3
6-K
EX-99.1
g9pd44
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
EX-99.1
8dj5ikpn
14 Sep 22
Current report (foreign)
10:31am
6-K
EX-99.2
3ipmen
29 Aug 22
Current report (foreign)
4:00pm
6-K
EX-99.1
5boomh7w4 7q2
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-99.2
u3hmtqo 1dey8gb1
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
6-K
EX-99.1
a25cepn
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
6-K
EX-99.2
vzaoyf 9tz05cphg
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.1
gax8wmu
15 Feb 22
Portage Biotech Announces New Appointments to its Management Team and Board of Directors
8:00am
6-K
EX-99.2
aekfn78olg
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
humvw
30 Aug 21
Current report (foreign)
5:21pm
6-K
EX-99.1
97u s798c7m7b1v
12 Aug 21
Portage Biotech Issues Letter to Shareholders
10:01am
SUPPL
44u63tb fwl
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
0avns95bz7r
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B2
08qdfumlt01bf9u
8 Mar 21
Prospectus for primary offering
5:00pm
6-K
EX-99.2
phny9gu8
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
F-3
egfwv
24 Feb 21
Shelf registration (foreign)
5:22pm